Pharmacotherapy and motor recovery after stroke

References

• Sousa RM, Ferri CP, Acosta D, et al. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population based survey. Lancet. 2009;374:1821–1830.
   PubMed Web of Science ®Google Scholar
• Hendricks HT, Van Limbeek J, Geurts AC, et al. Motor recovery after stroke: a systematic review of the literature. Arch Phys Med Rehabil. 2002;83:1629–1637.
   PubMed Web of Science ®Google Scholar
• Patel MD, McKevitt C, Lawrence E, et al. Clinical determinants of long-term quality of life after stroke. Age and Ageing. 2007;36:316–322.
   PubMed Web of Science ®Google Scholar
• Lledo MS, Alonso M, Grubb MS. Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci. 2006;7:179–193.
   PubMed Web of Science ®Google Scholar
• Chen R, Cohen LG, Hallett M. Nervous system reorganization following injury. Neuroscience. 2002;111:761–773.
   PubMed Web of Science ®Google Scholar
• Di Filippo M, Tozzi A, Costa C, et al. Plasticity and repair in the post-ischemic brain. Neuropharmacology. 2008;55:353–362.
   PubMed Web of Science ®Google Scholar
• Stroemer RP, Kent TA, Hulsebosch CE. Neocorticalneuralsprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke. 1995;26:2135–2144.
   PubMed Web of Science ®Google Scholar
• Wolf SL, Winstein CJ, Miller JP, et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke. Jama. 2006;296:2095–2104.
   PubMed Web of Science ®Google Scholar
• Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behavior. Nat Rev Neurosci. 2009;10:861–872.
   PubMed Web of Science ®Google Scholar
• Rossini PM, Dal Forno G. Neuronal post-stroke plasticity in the adult. Restor Neurol Neurosci. 2004;22:193–206.
   PubMed Web of Science ®Google Scholar
• Lo EH, Moskowitz MA, Jacobs TP. Exciting, radical, suicidal: how brain cells die after stroke. Stroke. 2005;36:189–192.
   PubMed Web of Science ®Google Scholar
• Graham SH, Chen J. Programmed cell death in cerebral ischemia. Cereb Blood Flow Metab. 2001;21:99–109.
   PubMed Web of Science ®Google Scholar
• Gascon S, Deogracias R, Sobrado M, et al. Transcription of the NR1 subunit of the N-methyl- D-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia. J BiolChem. 2005;280:35018–35027.
   PubMed Web of Science ®Google Scholar
• Takatsuru Y, Eto K, Kaneko R, et al. Critical role of the astrocyte for functional remodeling in contralateral hemisphere of somatosensory cortex after stroke. J Neurosc. 2013;33:4683–4692.
   PubMed Web of Science ®Google Scholar
• Xiong ZG, Zhu XM, Chu XP, et al. Neuroprotection in ischemia: blocking calcium-permeable acid sensing ion channels. Cell. 2004;118:687–698.
   PubMed Web of Science ®Google Scholar
• Clarkson AN, Huang BS, MacIsaac SE, et al. Reducing excessive GABA mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305–309.
   PubMed Web of Science ®Google Scholar
• Glykys J, Mody I. Activation of GABA A receptors: views from outside the synaptic cleft. Neuron. 2007;56:763–770.
   PubMed Web of Science ®Google Scholar
• Carmichael ST, Archibecque I, Luke L, et al. Growth-associated gene expression after stroke: evidence for a growth promoting region in peri-infarct cortex. Exp Neurol. 2005;193:291–311.
   PubMed Web of Science ®Google Scholar
• Tamatani M, Ogawa S, Nuñez G, et al. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 1998;5:911–919.
   PubMed Web of Science ®Google Scholar
• Clarkson AN, Overman JJ, Zhong S, et al. AMPA receptor induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. J Neurosci. 2011;31:3766–3775.
   PubMed Web of Science ®Google Scholar
• Blicher JU, Near J, Næss-Schmidt E, et al. GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement. Neurorehabil Neural Repair. 2015;29:278–286.
   PubMed Web of Science ®Google Scholar
• Talelli P, Greenwood RJ, Rothwell JC. Arm function after stroke: neurophysiological correlates and recovery mechanisms assessed by transcranial magnetic stimulation. Clin Neurophysiol. 2006;117:1641–1659.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Nogawa S, Ito D, et al. Activated phosphorylation of cyclic AMP response element binding protein is associated with preservation of striatal neurons after focal cerebral ischemia in the rat. Neuroscience. 2000;100:345–354.
   PubMed Web of Science ®Google Scholar
• Prasad MR, Ramaiah C, McIntosh TR, et al. Regional levels oflactate and norepinephrine after experimental brain injury. J Neurochem. 1994;63:1086–1094.
   PubMed Web of Science ®Google Scholar
• Dunn-Meynell A, Pan S, Levin BE. Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 hr. Brain Res. 1994;660:88–95.
   PubMed Web of Science ®Google Scholar
• Harley CW. Norepinephrine and dopamine as learning signals. Neural Plast. 2004;11:191–204.
   PubMedGoogle Scholar
• Kilgard MP, Merzenich MM. Cortical map reorganization enabled by nucleus basalis activity. Science. 1998;279:1714–1718.
   PubMed Web of Science ®Google Scholar
• Crisostomo EA, Duncan PW, Propst M, et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. 1988;23:94–97.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Danells CJ, Armesto A, et al. Physiotherapy coupled with dextroamphetamine for motor rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo controlled trial. Stroke. 2006;37:179–185.
   PubMed Web of Science ®Google Scholar
• Platz T, Kim IH, Engel U, et al. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomized, placebo controlled trial. Restor Neurol Neurosci. 2005;23:271–280.
   PubMed Web of Science ®Google Scholar
• Martinsson L, Wahlgren NG. Safety of dexamphetamine in acute ischemic stroke: a randomized double-blind, controlled dose-escalation trial. Stroke. 2003;34:475–481.
   PubMed Web of Science ®Google Scholar
• Schuster C, Maunz G, Lutz K, et al. Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial. Neurorehabil Neural Repair. 2011;25:749–755.
   PubMed Web of Science ®Google Scholar
• Treig T, Werner C, Sachse M, et al. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehab. 2003;17:590–599.
   PubMed Web of Science ®Google Scholar
• Lokk J, Salman Roghani R, Delbari A. Effect of methylphenidate and⁄or levodopa coupled with physiotherapy on functional and motor recovery after stroke – a randomized, double-blind, placebo-controlled trial. Acta Neurol Scand. 2011;123:66–273.
   Web of Science ®Google Scholar
• Wang QM, Cui H, Han SJ, et al. Combination of transcranial direct current stimulation and methylphenidate in subacute stroke. Neurosci Lett. 2014;569:6–11.
   PubMed Web of Science ®Google Scholar
• Grade C, Redford B, Chrostowski J, et al. Methylphenidate in early poststroke recovery : a double-blind, placebo-controlled study. Arch Phys Med Rehabil. 1998;79:1047–1050.
   PubMed Web of Science ®Google Scholar
• Barrett K, Brott T, Brown R. Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: results of a phase IIa clinical trial. J Stroke Cerebrovasc Dis. 2011;20:177–182.
   PubMed Web of Science ®Google Scholar
• Nadeau SE, Behrman AL, Davis SE, et al. Donepezil as an adjuvant to constraint-induced therapy for upper-limb dysfunction after stroke: an exploratory randomized clinical trial. J Rehabil Res Dev. 2004;41:525–534.
   PubMed Web of Science ®Google Scholar
• Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123–130.
   PubMed Web of Science ®Google Scholar
• Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in post stroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27:1211–1214.
   PubMed Web of Science ®Google Scholar
• Pariente J, Loubinoux I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol. 2001;50:718–729.
   PubMed Web of Science ®Google Scholar
• Acler M, Fiaschi A, Robol E, et al. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol. 2009;256:1152–1158.
   PubMed Web of Science ®Google Scholar
• Acler M, Fiaschi A, Manganotti P. Long term levodopa administration in chronic stroke patients. A clinical and neurophysiologic single blind placebo controlled cross over pilot study. Restor Neurol Neurosci. 2009;27:277–283.
   PubMed Web of Science ®Google Scholar
• Rösser N, Heuschmann P, Wersching H, et al. Levodopa improves procedural motor learning in chronic stroke patients. Arch Phys Med Rehabil. 2008;89:1633–1641.
   PubMed Web of Science ®Google Scholar
• Scheidtmann K, Fries W, Müller F, et al. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet. 2001;358:787–790.
   PubMed Web of Science ®Google Scholar
• Restemeyer C, Weiller C, Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci. 2007;25:143–150.
   PubMed Web of Science ®Google Scholar
• Nadeau SE, Lu X, Dobkin B. A prospective test of the late effects of potentially antineuroplastic drugs in a stroke rehabilitation study. Int J Stroke. 2014;9:449–456.
   PubMed Web of Science ®Google Scholar
• Schwitzguébel AJ, Benaïm C, Carda S, et al. GABAergic drug use and global, cognitive, and motor functional outcomes after stroke. Ann Phys Rehabil Med. 2016;59:320–325.
   PubMedGoogle Scholar
• Lazar RM, Berman MF, Festa JR, et al. GABA-ergic but not anti-cholinergic agents re-induce clinical deficits after stroke. J Neurol Sci. 2010;292:72–76.
   PubMed Web of Science ®Google Scholar
• Lazar RM, Fitzsimmons BF, Marshall RS, et al. Midazolam challenge reinduces neurological deficits after transient ischemic attack. Stroke. 2003;34:794–796.
   PubMed Web of Science ®Google Scholar
• Nadeau SE, Davis SE, Wu SS, et al. A pilot randomized controlled trial of D-cycloserine and distributed practice as adjuvants to constraint-induced movement therapy after stroke. Neurorehabil Neural Repair. 2014;28:885–895.
   PubMed Web of Science ®Google Scholar
• Cherry KM, Lenze EJ, Lang CE. Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke. J Neurophysiol. 2014;111:2516–2524.
   PubMed Web of Science ®Google Scholar
• Kirkwood A, Dudek SM, Gold JT, et al. Common forms of synaptic plasticity in the hippocampus and neocortex in vitro. Science. 1993;260:1518–1521.
   PubMed Web of Science ®Google Scholar
• Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron. 2011;69:628–649.
   PubMed Web of Science ®Google Scholar
• Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol. 1987;3:135–197.
   PubMed Web of Science ®Google Scholar
• Papadopoulos CM, Tsai SY, Guillen V, et al. Motor recovery and axonal plasticity with short-term. Stroke. 2009;40:294302.
   Web of Science ®Google Scholar
• Ramic M, Emerick AJ, Bollnow MR, et al. Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat. Brain Res. 2006;1111:176–186.
   PubMed Web of Science ®Google Scholar
• Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke. 1998;29:2381–2393.
   PubMed Web of Science ®Google Scholar
• Li Y, Kolb B, Robinson TE. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate–putamen. Neuropsychopharmacology. 2003;28:1082–1085.
   PubMed Web of Science ®Google Scholar
• Martinsson L, Hardermark H, Eksborg S. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev. 2007;24:CD002090.
   Google Scholar
• Čolović MB, Krstić DZ, Lazarević-Pašti TD, et al. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11:315–335.
   PubMed Web of Science ®Google Scholar
• Baskerville KA, Schweitzer JB, Herron P. Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. Neuroscience. 1997;80:1159–1169.
   PubMed Web of Science ®Google Scholar
• Flórez J, Armijo J, Mediavilla A. Farmacología Humana [Human Pharmacology]. 5th ed. Barcelona, España: Elsevier Masson; 2008.
   Google Scholar
• Lesch KP, Waider J. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron. 2012;76:175–191.
   PubMed Web of Science ®Google Scholar
• Coppell AL, Pei Q, Zetterström TS. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology. 2003;44:903–910.
   PubMed Web of Science ®Google Scholar
• Windle V, Corbett D. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Res. 2005;1044:25–32.
   PubMed Web of Science ®Google Scholar
• Chang YC, Tzeng SF, Yu L, et al. Early-life fluoxetine exposure reduced functional deficits after hypoxic-ischemia brain injury in rat pups. Neurobiol Dis. 2006;24:101–113.
   PubMed Web of Science ®Google Scholar
• Ng KL, Gibson EM, Hubbard R, et al. Fluoxetine maintains a state of heightened responsiveness to motor training early after stroke in a mouse model. Stroke. 2015;46:2951–2960.
   PubMed Web of Science ®Google Scholar
• Espinera AR, Ogle ME, Gu X, et al. Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice. Neuroscience. 2013;247:1–11.
   PubMed Web of Science ®Google Scholar
• Parikh RM, Robinson RG, Lipsey JR, et al. The impact of post-stroke depression on recovery in activities of daily living over a two-year follow up. Arch Neurol. 1990;47:785–789.
   PubMed Web of Science ®Google Scholar
• Jacobs BL, Fornal CA. Serotonin and motor activity. Curr Opin Neurobiol. 1997;7:820–825.
   PubMed Web of Science ®Google Scholar
• Hankey GJ. Selective serotonin reuptake inhibitors and risk of cerebral bleeding. Stroke. 2014;45:1917–1918.
   PubMed Web of Science ®Google Scholar
• Luft AR, Buitrago MM. Stages of motor skill learning. Mol Neurobiol. 2005;32:205–216.
   PubMed Web of Science ®Google Scholar
• Sawaguchi T. The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task. Neurosci Res. 2001;41:115–128.
   PubMed Web of Science ®Google Scholar
• Hosp JA, Molina-Luna K, Hertler B, et al. Dopaminergic modulation of motor maps in rat motor cortex: an in vivo study. Neuroscience. 2009;159:692–700.
   PubMed Web of Science ®Google Scholar
• Ruscher K, Kuricn E, Wieloch T. Levodopa treatment improves functional recovery after experimental stroke. Stroke. 2012;43:507–513.
   PubMed Web of Science ®Google Scholar
• Floel A, Breitenstein C, Hummel F, et al. Dopaminergic influences on formation of a motor memory. Ann Neurol. 2005;58:121–130.
   PubMed Web of Science ®Google Scholar
• Floel A, Hummel F, Breitenstein C, et al. Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology. 2005;65:472–474.
   PubMed Web of Science ®Google Scholar
• Van Hasselt P. Effect of butyrophenones on motor function in rats after recovery from brain damage. Neuropharmacology. 1973;12:245–247.
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Bullman S. Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabil Neural Repair. 2002;16:321–325.
   PubMed Web of Science ®Google Scholar
• Goldstein LB. Common drugs may influence motor recovery after stroke. The Sygen in acute stroke study investigators. Neurology. 1995;45:865–871.
   PubMed Web of Science ®Google Scholar
• Conroy B, Zorowitz R, Horn SD, et al. An exploration of central nervous system medication use and outcomes in stroke rehabilitation. Arch Phys Med Rehabil. 2005;86:73–81.
   PubMed Web of Science ®Google Scholar
• Catoira NP, Viale L, Di Girolamo G, et al. New centrally acting agents for appetite control: from biological mechanisms to clinical efficacy. Curr Med Res Opin. 2014;30:961–969.
   PubMed Web of Science ®Google Scholar
• Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35:1769–1775.
   PubMed Web of Science ®Google Scholar
• Patsalos PN, Berry DJ, Burgeois BF, et al. Antiepileptic drugs–best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies. Epilepsia. 2008;49:1239–1276.
   PubMed Web of Science ®Google Scholar
• Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res. 1986;376:71–77.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shuaib A, Li Q, et al. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res. 1998;804:169–176.
   PubMed Web of Science ®Google Scholar
• Edmonds HL, Jiang YD, Zhang PY, et al. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci. 2001;69:2265–2277.
   PubMed Web of Science ®Google Scholar
• Choi JW, Kim WK. Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury? Exp Neurol. 2007;203:5–7.
   PubMed Web of Science ®Google Scholar
• Clarkson AN, Huang BS, MacIsaac SE. Reducing excessive GABAergic tonic inhibition promotes poststroke functional recovery. Nature. 2011;468:305–309.
   Web of Science ®Google Scholar
• Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res. 1986;379:104–111.
   PubMed Web of Science ®Google Scholar
• Markowitz GJ, Kadam SD, Smith DR, et al. Different effects of high- and low-dose phenobarbital on poststroke seizure suppression and recovery in immature CD1 mice. Epilepsy Res. 2011;94:138–148.
   PubMed Web of Science ®Google Scholar
• López-Valdés HE, Clarkson AN, Ao Y, et al. Memantine enhances recovery from stroke. Stroke. 2014;45:2093–2100.
   PubMed Web of Science ®Google Scholar
• Guastella AJ, Richardson R, Lovibond PF, et al. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry. 2008;63:544–549.
   PubMed Web of Science ®Google Scholar
• Dhawan J, Benveniste H, Nawrocky M, et al. Transient focal ischemia results in persistent and widespread neuroinflammation and loss of glutamate NMDA receptors. Neuroimage. 2010;51:599–605.
   PubMed Web of Science ®Google Scholar
• Flores JJ, Zhang Y, Klebe DW, et al. Small molecule inhibitors in the treatment of cerebral ischemia. Expert Opin Pharmacother. 2014;15:659–680.
   PubMed Web of Science ®Google Scholar